Bentham Science Neuroscience Collection

 

Neuroscience

THE COLLECTION INCLUDE ARTICLES FROM THESE JOURNALS

 

CN_4-4.jpg CNSAMC.JPG cnsnddt-flyer.jpg carcnr-flyer

and many more Books…

✔ 130 Journals

✔ 7 Book Series

✔ 45 Books in Total 

 

FEATURES AND BENEFITS: 

♦ Access to over 11,130 scholarly articles covering several aspects of Neuroscience

♦ Contents come from more than 100 Bentham Science Journals

♦ Includes both; Original Research and Review Articles

♦ Research from leading institutions in USA, EUROPE, AUSTRALIA, JAPAN, CHINA and other regions

♦ Suitable for researchers in industry and academia wishing to keep updated with latest developments

♦ Easy access to institutions and individuals through IP-based authentication

♦ Access new Neuroscience Research included in this collection as soon as it is published

 

FLEXIBLE PACKAGES 

 Over 2,000 articles from 2017-2018
 Over 3,000 articles from the last 3 years 
 More than 10,000 articles from the last 10 years

 

Annual addition of over 900 Neuroscience related articles each year

Tailor-made packages available for pharmaceuticals companies, research institutes, universities, hospitals, clinical/academic societies, and corporations.

You can also send your librarian’s contact information to us at marketing@benthamscience.net  CC: hermain@benthamscience.net

To learn more about our Neuroscience Collection, please visit our website: http://bit.ly/2tOEZRo

New Issue | Current Neurovascular Research; Volume 16 Issue 3

 

Current Neurovascular Research provides a cross platform for the publication of scientifically rigorous research that addresses disease mechanisms of both neuronal and vascular origins in neuroscience. The journal serves as an international forum publishing novel and original work as well as timely neuroscience research articles, full-length/mini reviews in the disciplines of cell developmental disorders, plasticity, and degeneration that bridges the gap between basic science research and clinical discovery. Current Neurovascular Research emphasizes the elucidation of disease mechanisms, both cellular and molecular, which can impact the development of unique therapeutic strategies for neuronal and vascular disorders.

 

cnr-flyer.jpg

 

Articles from the journal: Current Neurovascular Research; Volume 16 Issue 3

For details on the articles, please visit this link: http://www.eurekaselect.com/node/608/current-neurovascular-research/issue/16/2581/3/9238

Most Accessed Articles | Extracranial-to-Intracranial Bypass for Pressor Dependent Cerebrovascular Insufficiency: Modified Classification and Representative Case

While some randomized clinical trials have reduced the indications for cerebral revascularization in the secondary prevention of ischemic stroke, a distinct subset of patients with blood pressure augmentation dependent cerebrovascular insufficiency due to large vessel occlusions remains unaddressed. With the recent paradigm shifts in acute ischemic stroke care, the role of extracranial to intracranial (EC-IC) bypass must be re-addressed when endovascular intervention is not a feasible option. We submit a refined classification of cerebrovascular insufficiency with a category called Pressor-Dependent Cerebrovascular Insufficiency (PD-CVI) for whom EC-IC bypass may be indicated. Read out full article here: http://www.eurekaselect.com/163730

 

ci.jpg

Wishing you a very Happy Birthday | Prof. Kenneth Maise

 

Prof Kenneth Maiese.jpg

Prof. Kenneth Maise

Editor-in-Chief: Current Neurovascular Research

 

Neurology and Neurosciences UMDNJ
205 South Orange Avenue, F1220
Newark, NJ 07101
USA

Aims & Scope – Current Neurovascular Research

Aims & Scope:

 

Current Neurovascular Research provides a cross platform for the publication of scientifically rigorous research that addresses disease mechanisms of both neuronal and vascular origins in neuroscience. The journal serves as an international forum publishing novel and original work as well as timely neuroscience research reviews in the disciplines of cell developmental disorders, plasticity, and degeneration that bridges the gap between basic science research and clinical discovery. Current Neurovascular Research emphasizes the elucidation of disease mechanisms, both cellular and molecular, which can impact the development of unique therapeutic strategies for neuronal and vascular disorders.

 

cnr-flyer.jpg

For more details, please visit: https://benthamscience.com/journals/current-neurovascular-research/aims-scope/#top

Most Accessed Articles – Positron Emission Tomography and Autoradiography Imaging of P-selectin Activation Using 68Ga-Fucoidan in Photothrombotic Stroke

Author(s): Ina Israel, Felix Fluri, Fabian Schadt, Andreas K. Buck, Samuel Samnick*.

Abstract:

Background: P-selectin is activated early after stroke, followed by a rapid decline. This time course can be used to generate important information on stroke onset. The latter is crucial for therapeutic decision-making of wake-up strokes (i.e. thrombolysis or not). Here, we evaluated the specific p-selectin inhibitor fucoidan labeled with gallium-68 (68Ga-Fucoidan) as an imaging biomarker for assessing p-selectin activation in acute ischemic stroke using Positron Emission Tomography (PET).

Methods: 68Ga-Fucoidan was investigated in rats brain at 2-5 h (n=16), and additionally at 24-26 h (n=9) and 48 h (n=3) after induction of photothrombic stroke or in sham-operated animals (n=6). Correlation of cerebral 68Ga-Fucoidan uptake with p-selectin expression was determined by exposing freshly cut brain cryosections to autoradiography and immunostaining using specific antibodies against p-selectin.

Results: PET scans showed an increased accumulation of 68Ga-Fucoidan in the histologically proven ischemic stroke, as compared to the corresponding contralateral hemisphere in all except one animal. The median ratio between the uptake in the ischemic lesion and the contralateral region was 1.95 (1.45-2.41) at 2-5 h, 1.38 (1.05-1.89) at 24-26 h, and 1.09 (0.81-1.38) at 48 h after stroke, compared to 1.22 (0.99-1.49) for sham-operated animals. In the ex vivo autoradiography, 68Ga-Fucoidan accumulation co-localized with p-selectin as assessed by immunostaining. Control animals and those scanned at 24-26 h and 48 h after stroke exhibited no elevated 68Ga-Fucoidan uptake in either hemisphere.

Conclusion: PET imaging using 68Ga-Fucoidan represents a valuable tool for assessing p-selectin activation in vivo discriminating ischemic stroke early after stroke onset.

 

 

For more details, please visit: http://www.eurekaselect.com/160550

Open Access Articles – A Novel Neuroimaging Model to Predict Early Neurological Deterioration After Acute Ischemic Stroke

Journal Name: Current Neurovascular Research

Author(s): Yen-Chu Huang*, Yuan-Hsiung Tsai, Jiann-Der Lee, Jen-Tsung Yang, Yi-Ting Pan.

Abstract:

Objective: In acute ischemic stroke, early neurological deterioration (END) may occur in up to one-third of patients. However, there is still no satisfying or comprehensive predictive model for all the stroke subtypes. We propose a practical model to predict END using magnetic resonance imaging (MRI).

Method: Patients with anterior circulation infarct were recruited and they underwent an MRI within 24 hours of stroke onset. END was defined as an elevation of ≥2 points on the National Institute of Health Stroke Scale (NIHSS) within 72 hours of stroke onset. We examined the relationships of END to individual END models, including: A, infarct swelling; B, small subcortical infarct; C, mismatch; and D, recurrence.

Results: There were 163 patients recruited and 43 (26.4%) of them had END. The END models A, B and C significantly predicted END respectively after adjusting for confounding factors (p=0.022, p=0.007 and p<0.001 respectively). In END model D, we examined all imaging predictors of Recurrence Risk Estimator (RRE) individually and only the “multiple acute infarcts” pattern was significantly associated with END (p=0.032). When applying END models A, B, C and D, they successfully predicted END (p<0.001; odds ratio: 17.5[95% confidence interval: 5.1– 60.8]), with 93.0% sensitivity, 60.0% specificity, 45.5% positive predictive value and 96.0% negative predictive value.

Conclusion: The results demonstrate that the proposed model could predict END in all stroke subtypes of anterior circulation infarction. It provides a practical model for clinical physicians to select high-risk patients for more aggressive treatment to prevent END.

For more details, please visit: http://www.eurekaselect.com/162202

World Stroke Day, 2018!

 

world-stroke-day-bentham-science-avail-discount-banner-3

Around 80 million people living in the world today have experienced a stroke and over 50m survivors live with some form of permanent disability as a result. While for many, life after stroke won’t be quite the same, with the right care and support living a meaningful life is still possible. As millions of stroke survivors show us every day, it is possible to get #UpAgainAfterStroke.

 

Bentham Science publishes articles related to World Stroke Day in its Subscription based journals including:

 

TO AVAIL 20% DISCOUNT ON RELATED EBOOKS, KINDLY VISIT: HTTPS://EBOOKS.BENTHAMSCIENCE.COM/

 

New Issue :: Current Neurovascular Research (Volume: 15, Issue: 2)

Current Neurovascular Research provides a cross platform for the publication of scientifically rigorous research that addresses disease mechanisms of both neuronal and vascular origins in neuroscience. The journal serves as an international forum publishing novel and original work as well as timely neuroscience research reviews in the disciplines of cell developmental disorders, plasticity, and degeneration that bridges the gap between basic science research and clinical discovery. Current Neurovascular Research emphasizes the elucidation of disease mechanisms, both cellular and molecular, which can impact the development of unique therapeutic strategies for neuronal and vascular disorders.

 

cnr.jpg

 

Articles from the Current Neurovascular Research Volume 15, Issue 2:

 

For details on the articles, please visit this link ::  https://bit.ly/2KzPV86

 

 

 

New Issue:: Current Neurovascular Research Volume 14, Issue 4

Current Neurovascular Research provides a cross platform for the publication of scientifically rigorous research that addresses disease mechanisms of both neuronal and vascular origins in neuroscience. The journal serves as an international forum publishing novel and original work as well as timely neuroscience research reviews in the disciplines of cell developmental disorders, plasticity, and degeneration that bridges the gap between basic science research and clinical discovery. Current Neurovascular Research emphasizes the elucidation of disease mechanisms, both cellular and molecular, which can impact the development of unique therapeutic strategies for neuronal and vascular disorders.

cnr

Articles from the journal Current Neurovascular Research Volume 14, Issue 4:

                              For details on the articles, please visit this link:: http://bit.ly/2BdX6ye

%d bloggers like this: